Skip to main content
. 2013 Oct 19;3(10):e003724. doi: 10.1136/bmjopen-2013-003724

Table 2.

Baseline characteristics between groups

IAS No IAS p Value IAC No IAC p Value
Age, years 72.6 (11.9) 66.0 (14.3) <0.0001 71.7 (11.2) 57.7 (14.9) <0.0001
Male 65 (62%) 303 (55%) 0.200 252 (57%) 116 (54%) 0.452
Index stroke
 Ischaemic 82 (78%) 409 (74%) 0.462 340 (77%) 151 (70%) 0.068
 TIA 23 (22%) 142 (26%) 101 (23%) 64 (30%)
 NIHSS, units 5 (2–11) 4 (2–9) 0.141 4 (2–9) 3 (1–8) 0.013
 Onset until CTA, minutes 155.4 (120.6) 148.5 (118.0) 0.655 148.7 (100.9) 151.4 (148.3) 0.115
Medical history
 Stroke 27 (26%) 91 (17%) 0.026 95 (22%) 23 (11%) 0.001
 TIA 12 (12%) 39 (7.1%) 0.159 39 (8.9%) 12 (5.6%) 0.163
 Ischaemic heart disease 22 (21%) 56 (10%) 0.003 69 (16%) 9 (4.2%) <0.0001
 Congestive heart failure 9 (8.7%) 23 (4.2%) 0.076 29 (6.6%) 3 (1.4%) 0.003
Stroke risk factors
 Hypertension 85 (81%) 312 (57%) <0.0001 308 (70%) 89 (42%) <0.0001
 Diabetes 11 (11%) 46 (8.3%) 0.453 47 (11%) 10 (4.7%) 0.011
 Hypercholesterolaemia 79 (78%) 333 (64%) 0.008 294 (71%) 118 (57%) 0.001
 Atrial fibrillation 20 (19%) 136 (25%) 0.260 118 (27%) 38 (18%) 0.011
 Smoking history 52 (53%) 263 (51%) 0.743 222 (54%) 93 (48%) 0.033
 Alcohol misuse 16 (17%) 60 (12%) 0.176 63 (15%) 13 (6.4%) 0.002
Laboratory values
 Cholesterol, mmol/L* 5.2 (1.1) 5.3 (1.1) 0.364 5.31 (1.1) 5.32 (1.1) 0.901
 LDL, mmol/L* 3.2 (1.0) 3.3 (1.0) 0.224 3.3 (1.0) 3.3 (0.9) 0.737
 HDL, mmol/L* 1.3 (0.3) 1.4 (0.5) 0.812 1.4 (0.4) 1.4 (0.5) 0.787
 Triglycerides, mmol/L* 1.5 (0.9) 1.4 (0.8) 0.838 1.4 (0.9) 1.3 (0.7) 0.516
 Glucose, mmol/L 6.5 (1.8) 6.4 (2.0) 0.116 6.5 (1.9) 6.2 (2.1) 0.001
 eGFR, ml/min/1.73 m2 70.4 (20.4) 77.8 (21.1) 0.001 74.4 (21.6) 81.2 (19.7) <0.0001
Radiological observations
 Extracranial carotid stenosis 20 (19%) 48 (8.7%) 0.003 60 (14%) 8 (3.7%) <0.0001
 Atherosclerotic carotid lesions 80 (76%) 251 (46%) <0.0001 288 (65%) 43 (20%) <0.0001
 Atherosclerotic aorta lesions 75 (71%) 237 (43%) <0.0001 275 (48%) 37 (17%) <0.0001

*Only patients not on prestroke statin treatment.

IAC, intracranial arterial calcifications; IAS, intracranial arterial stenosis; CTA, CT angiography; eGFR, estimated glomerular filtration rate; HDL, high-density lipoprotein; LDL, low-density lipoprotein; NIHSS; National Institute of Health Stroke Scale.